Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide as Adjunctive Therapy in Uncontrolled Partial Epilepsy
NCT01140867Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Feb 2008
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of zonisamide in partial epilepsy, sponsored by Eisai Co., Ltd. Primary endpoint: Seizure Reduction Rate at 16 weeks. Started Feb 2008; status: completed.
02
Drugs
zonisamide
03
Conditions
partial epilepsy
Beyond the preview
Go deeper on NCT01140867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01140867.